Brenda Huska, Canada
Northern Ontario School of Medicine Medical SciencesAuthor Of 1 Presentation
IMMUNOGENICITY OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) IN 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV23)-NAÏVE AND PREVIOUSLY IMMUNIZED ADULT PATIENTS WITH SEVERE CHRONIC KIDNEY DISEASE (ID 188)
Session Name
Vaccines - Pneumococcal Vaccines Development
Presenter